24
Participants
Start Date
May 25, 2017
Primary Completion Date
November 27, 2017
Study Completion Date
November 27, 2017
Sublingual tablet 4 mg versus Nicorette Lozenge 4mg
"* One dose of study drug (sublingual tablet or Nicorette Lozenge) will be administered to each subject in the morning on Day 1.~* The second administration of drug will occur at least 48 hours after the initial administration. Subjects will receive the other dosage form and be instructed according to whether they are receiving the sublingual tablet or the lozenge."
Rose Research Center, Raleigh
Lead Sponsor
Rose Research Center, LLC
INDUSTRY
Friends Research Institute, Inc.
OTHER